Related Experiment Video
Updated: Feb 10, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Stormram 4: An MR Safe Robotic System for Breast Biopsy
Vincent Groenhuis1, Françoise J Siepel2, Jeroen Veltman2
1Department of Robotics and Mechatronics, University of Twente, att. Vincent Groenhuis, Room CR-3.526, Postbus 217, 7500AE, Enschede, The Netherlands. v.groenhuis@utwente.nl.
A novel robotic system, Stormram 4, offers accurate magnetic resonance imaging (MRI)-guided breast biopsies. This MR-safe robot precisely targets lesions, reducing tissue damage and potential false negatives for improved diagnostic accuracy.
Area of Science:
- Medical Robotics
- Diagnostic Imaging
- Surgical Navigation
Background:
- Accurate biopsy of MRI-detected breast lesions is crucial for diagnosis.
- Current methods may face challenges in precision and efficiency.
- Minimally invasive techniques are needed to reduce patient risk.
Purpose of the Study:
- To introduce the Stormram 4, a novel robotic system for MRI-guided breast biopsies.
- To evaluate the preclinical performance of the Stormram 4 within an MRI environment.
- To assess the system's accuracy, safety, and potential for clinical application.
Main Methods:
- Development of the Stormram 4 robotic system, featuring pneumatic stepper motors.
- Preclinical testing of the robot in free air and within an MRI environment using breast phantoms.
- Measurement of positioning error and assessment of MR safety.
Main Results:
- The Stormram 4 robot demonstrated a mean positioning error of 0.73 ± 0.47 mm in free air and 1.29 ± 0.59 mm in MRI.
- The system operates effectively within the MRI environment, with stepping frequencies up to 8 Hz under load.
- The robot is inherently MR safe, excluding the biopsy needle.
Conclusions:
- The Stormram 4 robot shows significant promise for accurate MRI-guided breast biopsies.
- Its precision and MR safety can potentially minimize tissue damage and reduce false negatives.
- Further clinical studies are warranted to validate its efficacy in improving healthcare quality for breast cancer diagnosis.
More Related Videos
06:42Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
Published on: September 2, 2025
07:51The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
Related Concept Videos
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Dipeptidyl Peptidase 4 Inhibitors
Piaget's Stage 4 of Cognitive Development
Abstract Reasoning and Hypothetical-Deductive Thinking
Unlike the concrete operational...
Amides to Amines: LiAlH4 Reduction
Amide reduction requires two equivalents of the reducing agent, acting as a source of hydride ions. As shown in the figure, the reaction is initiated with a nucleophilic attack by the hydride ion at the carbonyl carbon to form a tetrahedral intermediate.
Nitriles to Amines: LiAlH4 Reduction
As shown below, the mechanism involves three steps. Firstly, the hydride ion acting as a nucleophile attacks the nitrile carbon to form an anion. In the second step, a second equivalent of the hydride ion attacks the anion to...
Design Example: Calculating Safe Diameter for Wind-Exposed Disc